Print pageHome » FDA Publishes Updated Barcode Label Q&A
FDA Publishes Updated Barcode Label Q&A
rx-360.org
PharmaManufacturing.com
09/13/2011
FDA published a revised Guidance for industry: Bar Code Label Requirements---Questions and Answers, on August 11, 2011. This revision amends the response to Question 12 of the October 2006 guidance and allows vaccine manufacturers to use “alternative coding technologies” to linear bar code technology.
FDA feels this is necessary based on the mandatory recordkeeping requirements associated with administration of childhood vaccines. Administration generally occurs in a physician office or clinical that may have limited administrative support to record the necessary data for each administration and use of alternative coding technologies may facilitate collection and recording of this information.
To view or download the FDA's Q&A, click here
To view or download the FDA's Update Q&A, click here
More News:
-
05/22/2013
Novo Acquires Xellia Pharmaceuticals for $700 MillionFrom PharmaTimes Online
Novo A/S has acquired Xellia Pharmaceuticals of Norway
-
05/22/2013
Royalty Increases Bid as Elan Unveils AcquisitionsFrom PharmaTimes Online
Royalty Pharma has resurfaced to raise its bid to acquire the Irish drugmaker Elan
-
05/22/2013
New Asthma Drug Offers Hope for PatientsFrom Forbes
An experimental asthma drug could give new hope to patients for whom existing medicines are not enough
-
05/21/2013
Syrian Pharma Production Nearly Halted by WarFrom AFP
A shortage of foreign currency has brought production to a near halt in Syria
-
05/21/2013
Camfil APC Opens Manufacturing Plant in the UKFrom Camfil
Camfil announced the grand opening of its new 40,000-sq.-ft. facility
-
05/21/2013
Actavis Acquiring Warner Chilcott for $8.5BFrom AP
Actavis to buy Warner Chilcott in an all-stock transaction
-
05/17/2013
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
-
05/16/2013
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
-
05/16/2013
$15 Billion Myland Offer Rejected By ActavisFrom Bloomberg.com
Actavis has rejected drugmaker Mylan Inc's cash-and-stock offer for $15 billion. They have decided to continue talks to take over Warner Chilcott Plc instead, sources have said.
-
05/15/2013
Rapid Micro Biosystems Offers Workshops at New European Headquarters in MunichFrom Rapid Micro Biosystems
Company hosts hands-on demonstrations of its Growth Direct System
- All news »
Get Connected Now!
- Featured White Papers
Sponsored Links
